Drug Information

Drug General Information
Drug ID
D08VBB
Former ID
DIB000309
Drug Name
Selective androgen receptor degraders
Synonyms
Selective androgen receptor degraders (prostate cancer); Selective androgen receptor degraders (prostate cancer), Aragon Pharmaceuticals; SARDs (castration-resistant prostate cancer), Aragon Pharmaceuticals
Indication Hormone refractory prostate cancer [ICD9: 140-229, 185; ICD10:C61] Investigative [1572605]
Company
Aragon Pharmaceuticals Inc
Target and Pathway
Target(s) Androgen receptor Target Info Modulator [1572605]
KEGG Pathway Oocyte meiosis
Pathways in cancer
Prostate cancer
NetPath Pathway EGFR1 Signaling Pathway
AndrogenReceptor Signaling Pathway
FSH Signaling Pathway
Pathway Interaction Database Regulation of nuclear SMAD2/3 signaling
Coregulation of Androgen receptor activity
Regulation of Androgen receptor activity
Nongenotropic Androgen signaling
Regulation of nuclear beta catenin signaling and target gene transcription
FOXA1 transcription factor network
Notch-mediated HES/HEY network
Reactome Nuclear Receptor transcription pathway
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
WikiPathways SIDS Susceptibility Pathways
Integrated Pancreatic Cancer Pathway
Prostate Cancer
Integrated Breast Cancer Pathway
Nuclear Receptors
Androgen receptor signaling pathway
References
Ref 1572605The ChEMBL database in 2017.
Ref 1572605The ChEMBL database in 2017.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.